Thymosin-α1 (4.5mg)
$80.00
This product is supplied for laboratory research use only and is not intended for human use. Lyophilized products may require appropriate laboratory reconstitution and handling.
Description
Thymosin alpha-1, a naturally occurring peptide segment, was initially identified back in 1972. Subsequently, it has undergone extensive examination in clinical trials across various medical conditions including cystic fibrosis, infections like tuberculosis and cytomegalovirus, respiratory disorders, chronic hepatitis, and cancer. Notably, it has secured approval for combatting chronic hepatitis B and C infections in 35 under-developed nations.
Additional Information
Benefits
Please review the complete product description and available supporting documentation for product-specific research information. This product is sold strictly for laboratory research use.
Mechanism of Action
Refer to the product description, certificate of analysis and applicable published research for product-specific information. No medical or therapeutic claims are made.
